Clinical research results now to be more transparent

Due to a “credibility gap”, drugmakers are now being moved to make reports on clinical research results more transparent, whether the results are good or bad. According to an article on mednews.com by Kevin B. O’Reilly, there have been 10 approved recommendations on improving transparency, including, among others, making all results public, disclosing who is making what writing contributions, and providing complete information on trial protocol and statistical methods used. Although this incentive is being applauded, the real question is whether the pharmaceutical companies will actually do it. To read more on this subject, check out the article here.